Skip to content

Mucosal Integrity Conductivity (MI) Test System

by Diversatek Healthcare, Inc.

De Novo DEN180067

Active United States

De Novo

Valid until

No expiry

De Novo grant is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA De Novo, synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA De NovoDENG De Novo granted · Direct NumberDEN180067 Date23 Dec 2019DecidedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA De Novo Active

Specification

De Novo

De Novo Number
FDA product code
QIS
Device class
Class II
Regulation
21 CFR Part 876.1450
Advisory committee
Gastroenterology, Urology
FDA decision
DENG De Novo granted

Overview

AI-generated summary, 22 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Mucosal Integrity Conductivity (MI) Test System is a device used to obtain a real-time measurement of esophageal epithelial impedance during endoscopy. It is indicated for use by gastroenterologists, surgeons, and medically trained personnel to support clinical decision-making in the evaluation of esophageal mucosal integrity.

The system is supplied as a point-of-care testing system for use during endoscopic procedures. It received De Novo classification from the FDA on December 23, 2019, under k-number DEN180067, and is classified as a Class II medical device with product code QIS and regulation number 876.1450.

From the manufacturer

MiVu™ Mucosal Integrity Testing System Join Our Live Webinar on September 22 MiVu™ provides objective, point-of-care data during endoscopy to instantly differentiate GERD, EoE, and Non-GERD and support more informed clinical decision-making.

Source: diversatekhealthcare.com

MiVu™ Mucosal Integrity Testing System MiVu can instantly rule out GERD during index endoscopy, and potentially obviates the need for 24 to 48 hour ambulatory wireless pH monitoring.

Source: diversatekhealthcare.com

Other devices from Diversatek Healthcare

See all devices from Diversatek Healthcare →

Questions

AI-generated answers, 22 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Mucosal Integrity Conductivity (MI) Test System used for?

    The Mucosal Integrity Conductivity (MI) Test System is used to obtain real-time measurements of esophageal epithelial impedance during endoscopy. It supports clinical decision-making by gastroenterologists, surgeons, and medically trained personnel in evaluating esophageal mucosal integrity.

  • How is the Mucosal Integrity Conductivity (MI) Test System supplied and used?

    The system is supplied as a point-of-care testing system designed for use during endoscopic procedures. It is intended to be used by trained medical personnel at the point of care to obtain impedance measurements in real time while performing endoscopy.

  • Is the Mucosal Integrity Conductivity (MI) Test System a single-use or reusable device?

    The device data does not specify whether components of the Mucosal Integrity Conductivity (MI) Test System are single-use or reusable. Therefore, no determination about reusability can be made from the provided information.

  • What regulatory pathway was used for the Mucosal Integrity Conductivity (MI) Test System?

    The Mucosal Integrity Conductivity (MI) Test System received De Novo classification from the FDA on December 23, 2019, under k-number DEN180067, and is classified as a Class II medical device with product code QIS and regulation number 876.1450.